Foxconn and blood iPhones?
For Terry Gou, 2010 should have been a good year. He topped the Forbes billionaire list as the richest man in Taiwan and his company Foxconn was listed as 112th in Fortune’s ‘Global 500’ rankings and appeared again on the ‘Most Admired Companies’ list for 2010. Life suddenly changed for Gou with a spate of suicides at his South China factory in Shenzhen where iPhones are made. Foxconn’s lack of response until the 11th suicide could potentially damage the company’s reputation. Over many years Foxconn had built up an enviable customer list of global brand names such as Apple. It also expanded into different areas within and beyond consumer electronics becoming a global player and significantly larger than its closest competitors. This case explores the actions Foxconn took as a result of the suicides and the challenges facing Foxconn into the future.
The Foxconn case deals with ethical and reputational challenges related to the multinational companies and outsourcing companies in developing countries. The case aims to facilitate debate over dilemma situations: conflicting stakeholder power/interests; short term vs long term profitability; economic interest vs wellbeing; blaming vs supporting the supplier’s misconduct; and reputation of the subcontractor vs the MNCs. In particular, international audiences will benefit from discussing differences in values and moral standards between the East and the West.
Foxconn
2011
Cranfield University
Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]
Harvard Business School Publishing
60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]
NUCB Business School
1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
Research Information & Knowledge Hub for additional information on IMD publications
The Sandoz leadership team faced an important decision as it broke away from Novartis and became a public company. Should Sandoz retain the global geographical coverage it had had in its many years as part of Novartis? Or should it focus on fewer ...
This case series explores Sandoz's spin off from Novartis, which was finalized on 4 October 2023. Case A follows Richard Saynor's (CEO, Sandoz) ruminations as he builds the company strategy in preparation for the board's approval of Sandoz as a st...
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Case reference: IMD-2669 ©2025
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD Brain Circuits 4 September 2025
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications